BCN Peptides is a privately held company established in 1989, specializing in the cGMP Industrial Manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. The company's slogan "The Art of Making Peptides" reflects its core focus. BCN Peptides boasts a strong track record of GMP compliance, holding approvals from key regulatory bodies such as the FDA and EDQM. Additionally, it holds multiple CEPs from the European Pharmacopoeia. The company's key activities revolve around GMP Bulk Generic Peptides and Custom Synthesis of proprietary API Peptides, with the capacity to manufacture multi-kilo batches of GMP Peptides using SPPS technology. Despite lacking specific details about the headquarters or any last investment, BCN Peptides' focus on pharmaceutical and veterinary applications, along with its impressive track record, positions it as a notable player in the Biotechnology and Manufacturing industries.
There is no investment information
No recent news or press coverage available for BCN Peptides.